Literature DB >> 18667850

Effect of PEL exopolysaccharide on the wspF mutant phenotypes in Pseudomonas aeruginosa PA14.

In-Young Chung1, Kelly B Choi, Yun-Jeong Heo, You-Hee Cho.   

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen that produces and secretes exopolysaccharides (EPS), in which cells are embedded to form a highly organized community structure called biofilm. Here, we characterized the role of cyclic diguanylate (c-di-GMP) and EPS (PEL) overproduction in the wspF mutant phenotypes of P. aeruginosa PA14 (wrinkly appearance, hyperadherence, impaired motilities, and reduced virulence in acute infections). We confirmed that the elevated c-di-GMP level plays a key role in all the wspF mutant phenotypes listed above, as assessed by ectopic expression of a c-di-GMP-degrading phophodiesterase (PvrR) in the wspF mutant. In contrast, PEL EPS, which is overproduced in the wspF mutant, was necessary for wrinkly appearance and hyperadherence, but not for the impaired flagellar motilities and the attenuated virulence of the wspF mutant. These results suggest that cdi- GMP affects flagellar motility and virulence, independently of EPS production and surface adherence of this bacterium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667850

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  10 in total

1.  Embedded biofilm, a new biofilm model based on the embedded growth of bacteria.

Authors:  Yong-Gyun Jung; Jungil Choi; Soo-Kyoung Kim; Joon-Hee Lee; Sunghoon Kwon
Journal:  Appl Environ Microbiol       Date:  2014-10-17       Impact factor: 4.792

2.  Differential expression of the major catalase, KatA in the two wild type Pseudomonas aeruginosa strains, PAO1 and PA14.

Authors:  Bi-O Kim; In-Young Chung; You-Hee Cho
Journal:  J Microbiol       Date:  2019-06-11       Impact factor: 3.422

3.  Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.

Authors:  In-Young Chung; Nuri Sim; You-Hee Cho
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

4.  Thermoregulation of Pseudomonas aeruginosa Biofilm Formation.

Authors:  Suran Kim; Xi-Hui Li; Hyeon-Ji Hwang; Joon-Hee Lee
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

5.  Antibiofilm effect of biofilm-dispersing agents on clinical isolates of Pseudomonas aeruginosa with various biofilm structures.

Authors:  Soo-Kyoung Kim; Xi-Hui Li; Hyeon-Ji Hwang; Joon-Hee Lee
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

6.  Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP.

Authors:  Bomin Kim; Ji-Su Park; Ha-Young Choi; Sang Sun Yoon; Won-Gon Kim
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

7.  The Nitrite Transporter Facilitates Biofilm Formation via Suppression of Nitrite Reductase and Is a New Antibiofilm Target in Pseudomonas aeruginosa.

Authors:  Ji-Su Park; Ha-Young Choi; Won-Gon Kim
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

8.  rpoS-mutation variants are selected in Pseudomonas aeruginosa biofilms under imipenem pressure.

Authors:  Xiangke Duan; Yanrong Pan; Zhao Cai; Yumei Liu; Yingdan Zhang; Moxiao Liu; Yang Liu; Ke Wang; Lianhui Zhang; Liang Yang
Journal:  Cell Biosci       Date:  2021-07-21       Impact factor: 7.133

9.  The pathogenicity island encoded PvrSR/RcsCB regulatory network controls biofilm formation and dispersal in Pseudomonas aeruginosa PA14.

Authors:  Helga Mikkelsen; Kailyn Hui; Nicolas Barraud; Alain Filloux
Journal:  Mol Microbiol       Date:  2013-06-28       Impact factor: 3.501

10.  Raffinose, a plant galactoside, inhibits Pseudomonas aeruginosa biofilm formation via binding to LecA and decreasing cellular cyclic diguanylate levels.

Authors:  Han-Shin Kim; Eunji Cha; YunHye Kim; Young Ho Jeon; Betty H Olson; Youngjoo Byun; Hee-Deung Park
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.